Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Paradigm Health announced the launch of a research collaboration with the FDA focused on advancing a new model to accelerate clinical trial execution and regulatory review.
read more
Mikart announced the opening of its new headquarters in Northwest Atlanta. The new executive headquarters represents a milestone in the company's growth and expansion.
read more
Andelyn Biosciences and ENCell announced the signing of a Collaboration Agreement to establish a strategic manufacturing bridge between the United States and Asia-Pacific (APAC) regions to accelerate the global delivery of gene therapies.
read more
Tivic Health Systems reported that it is changing its corporate name to Valion Bio, Inc. and will begin trading under the new Nasdaq ticker symbol VBIO effective at market open on April 28, 2026.
read more
Forge Biologics, a member of the Ajinomoto Bio-Pharma Services group, announced it has achieved My Green Lab® Certification, the global gold standard for laboratory sustainability best practices, across all of its laboratories and manufacturing ...
read more
Minaris, a CGT CDMO and multimodality biosafety testing provider and Chimeric Therapeutics, an Australian cell therapy company, announced a 100% batch manufacturing and release success rate in support of Chimeric Therapeutics' CDH17-targeted ...
read more
Mikart and Benuvia Operations announced a strategic co-marketing partnership to provide fully integrated, end-to-end solutions spanning drug substance (API) development through finished drug product manufacturing.
read more
Alcami Corporation has entered into a definitive agreement to acquire Tjoapack, a global contract packaging organization with facilities in the United States and The Netherlands.
read more
PCI Pharma Services announced a series of major infrastructure investments that substantially deepen its sterile fill-finish and advanced drug delivery capabilities.
read more
Simulations Plus announced a funded research collaboration with Lonza Group AG and the FDA to develop and validate a mechanistic, predictive framework for assessing the in vivo performance of amorphous solid dispersion (ASD) drug products.
read more
WuXi AppTec reported first-quarter 2026 total revenue of RMB 12.44 billion, an increase of 28.8% year over year, with revenue from continuing operations up 39.4%.
read more
Wednesday, April 22, 2026
Made Scientific and Regenicin announced a manufacturing relationship to advance NovaDerm, an autologous cultured skin substitute for severe burns and chronic wounds, toward a U.S. FDA Orphan product approval.
read more
The 2026 INTERPHEX Exhibitor Awards recognize innovative technologies that advance pharmaceutical and biopharmaceutical manufacturing, from cell culture media preparation and sterile connections to contamination control, filtration, single-use ...
read more
Integrated DNA Technologies (IDT), a Danaher company, announced the expansion of its manufacturing footprint in Coralville, Iowa. The investment delivers a more than threefold increase in synthesis capacity, enabling faster, more scalable production ...
read more
Eurofins CDMO Alphora announced the expansion of its Active Pharmaceutical Ingredient (API) manufacturing capabilities through the integration of advanced, custom-built Continuous Flow (CF) technology to its operations.
read more